Literature DB >> 1752776

Transformation of CD8+ T-cells producing a strong cytopathic effect on CD4+ T-cells through syncytium formation by HTLV-II.

K Miyamoto1, T Kamiya, J Minowada, N Tomita, K Kitajima.   

Abstract

Human T-cell leukemia virus type II (HTLV-II) is thought to play an important role in the development of CD8+ T-cell malignancies resembling hairy cell leukemia. In this study, dramatic cytopathic effects characterized by syncytium formation in various CD4+ T-cell lines were observed upon their cocultivation with HTLV-II infected T-cells. The HTLV-II infected T-cells, however, did not die as a result of syncytium formation. HTLV-II also transformed CD4+ T-cells and CD8+ T-cells at various coculture ratios. Furthermore, sera from anti-HTLV-II antibody-positive specific carriers inhibited syncytium formation in the CD4+ T-cells. These results suggest that HTLV-II infection may contribute to the pathogenesis of associated CD8+ T-cell malignancies.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1752776      PMCID: PMC5918317          DOI: 10.1111/j.1349-7006.1991.tb01775.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  14 in total

1.  High rate of HTLV-II infection in seropositive i.v. drug abusers in New Orleans.

Authors:  H Lee; P Swanson; V S Shorty; J A Zack; J D Rosenblatt; I S Chen
Journal:  Science       Date:  1989-04-28       Impact factor: 47.728

2.  Rapid progression to AIDS in dual HIV-1/HTLV-I infection.

Authors:  J J Lefrère; A M Couroucé; M Mariotti; E Wattel; O Prou; F Bouchardeau; P Lambin
Journal:  Lancet       Date:  1990-08-25       Impact factor: 79.321

3.  A second isolate of HTLV-II associated with atypical hairy-cell leukemia.

Authors:  J D Rosenblatt; D W Golde; W Wachsman; J V Giorgi; A Jacobs; G M Schmidt; S Quan; J C Gasson; I S Chen
Journal:  N Engl J Med       Date:  1986-08-07       Impact factor: 91.245

4.  HTLV-I associated myelopathy, a new clinical entity.

Authors:  M Osame; K Usuku; S Izumo; N Ijichi; H Amitani; A Igata; M Matsumoto; M Tara
Journal:  Lancet       Date:  1986-05-03       Impact factor: 79.321

5.  Establishment and characterization of adult T-cell leukemia virus-containing B-cell lines derived from peripheral blood of adult T-cell leukemia patients.

Authors:  K Miyamoto; N Tomita; A Ishii; T Nishizaki; A Togawa
Journal:  Gan       Date:  1984-08

6.  Pseudotypes of human T-cell leukemia virus types 1 and 2: neutralization by patients' sera.

Authors:  P Clapham; K Nagy; R A Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

7.  Human T-cell leukemia virus type II transforms normal human lymphocytes.

Authors:  I S Chen; S G Quan; D W Golde
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

8.  Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera.

Authors:  Y Hinuma; K Nagata; M Hanaoka; M Nakai; T Matsumoto; K I Kinoshita; S Shirakawa; I Miyoshi
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

9.  Prevalence of human T-cell leukemia/lymphoma virus (HTLV) type II infection among high-risk individuals: type-specific identification of HTLVs by polymerase chain reaction.

Authors:  G D Ehrlich; J B Glaser; K LaVigne; D Quan; D Mildvan; J J Sninsky; S Kwok; L Papsidero; B J Poiesz
Journal:  Blood       Date:  1989-10       Impact factor: 22.113

10.  Detection of provirus in an HTLV-II producer CD8+ T cell line by polymerase chain reaction combined with digoxigenin-ELISA method.

Authors:  K Miyamoto; N Tomita; Y Ohtsuki; K Kitajima
Journal:  Jpn J Cancer Res       Date:  1990-04
View more
  8 in total

Review 1.  Comparative biology of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2.

Authors:  Gerold Feuer; Patrick L Green
Journal:  Oncogene       Date:  2005-09-05       Impact factor: 9.867

2.  The tax gene of human T-cell leukemia virus type 2 is essential for transformation of human T lymphocytes.

Authors:  T M Ross; S M Pettiford; P L Green
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

3.  Human T-lymphocyte transformation with human T-cell lymphotropic virus type 2.

Authors:  S L Tarsis; M T Yu; E S Parks; D Persaud; J L Muñoz; W P Parks
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

4.  Tax and overlapping rex sequences do not confer the distinct transformation tropisms of human T-cell leukemia virus types 1 and 2.

Authors:  Jianxin Ye; Li Xie; Patrick L Green
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

5.  Human T Lymphotropic Virus Type 1 (HTLV-1): Molecular Biology and Oncogenesis.

Authors:  Priya Kannian; Patrick L Green
Journal:  Viruses       Date:  2010-09-24       Impact factor: 5.818

6.  Absence of HTLV-II co-infection in HTLV-I-associated myelopathy patients.

Authors:  K Miyamoto; T Nakamura; S Nagataki; N Tomita; K Kitajima
Journal:  Jpn J Cancer Res       Date:  1992-05

7.  HTLV-II non-integrated malignant lymphoma induction in Japanese white rabbits following intravenous inoculation of HTLV-II-infected simian leukocyte cell line (Si-IIA).

Authors:  K Hayashi; N Ohara; T R Koirala; H Ino; H L Chen; N Teramoto; E Kondo; T Yoshino; K Takahashi; M Yamada
Journal:  Jpn J Cancer Res       Date:  1994-08

8.  Southernmost carriers of HTLV-I/II in the world.

Authors:  L Cartier; F Araya; J L Castillo; V Zaninovic; M Hayami; T Miura; J Imai; S Sonoda; H Shiraki; K Miyamoto
Journal:  Jpn J Cancer Res       Date:  1993-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.